Literature DB >> 26559761

Pentoxifylline: An effective therapy for necrobiosis lipoidica.

Edmund Wee1, Robert Kelly1.   

Abstract

Necrobiosis lipoidica (NL) is a rare chronic inflammatory granulomatous skin disorder that remains challenging to treat. Here we report three patients at different stages of disease successfully treated with pentoxifylline, a haemorrheological and anti-inflammatory agent. We demonstrate for the first time that early stage NL may be completely reversible with this treatment. Our findings are also consistent with previous isolated reports showing the effectiveness of pentoxifylline in treating ulcerative NL.
© 2015 The Australasian College of Dermatologists.

Entities:  

Keywords:  atrophy; necrobiosis lipoidica; pentoxifylline; ulceration

Mesh:

Substances:

Year:  2015        PMID: 26559761     DOI: 10.1111/ajd.12420

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  3 in total

Review 1.  Dermatologic manifestations of endocrine disorders.

Authors:  Michael Lause; Alisha Kamboj; Esteban Fernandez Faith
Journal:  Transl Pediatr       Date:  2017-10

2.  Ulcerative necrobiosis lipoidica in the setting of anti-tumor necrosis factor-α and hydroxychloroquine treatment for rheumatoid arthritis.

Authors:  Jennifer Albus Fehlman; Nicole M Burkemper; Tricia A Missall
Journal:  JAAD Case Rep       Date:  2017-03-12

3.  Improvement of necrobiosis lipoidica with topical ruxolitinib cream after prior nonresponse to compounded topical tofacitinib cream.

Authors:  Shannon Nugent; Alexandra J Coromilas; Joseph C English; Misha Rosenbach
Journal:  JAAD Case Rep       Date:  2022-08-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.